Protease inhibitors are found widely in numerous organisms including microbes, plants and animals, where they regulate intracellular and extracellular protease activities. While purifying ribonuclease (RNase) from Spirometra (Spirometra erinaceieuropaei), we identified bovine pancreatic trypsin inhibitor (BPTI)-like protease inhinitor.
1. About 10 g of Spirometra was homogenated with 200 ml of ice-cold 0.25 N H 2 SO 4 containing 1 mM MgCl 2 for 5 min. The homogenate was then centrifuged at 10000 rpm for 10 min. The resulting supernatant was used as a crude extract.
Step 2. The supernatant (180 ml) was vigorously stirred with water-saturated phenol (60 ml), and the phenol layer was collected by centrifugation at 10000 rpm for 10 min. Icecold acetone (100 ml) was added to the phenol layer while cooling the solution with ice. The resulting precipitate was collected by centrifugation at 10000 rpm for 10 min. The precipitate was dissolved in 100 ml of de-ionized water and dialyzed against de-ionized water overnight using molecular weight 1000 cut dialysis tubing (Spectropore Lab. Gardena CA, U.S.A.) (phenol fractionation).
Step 3. Next the dialyzate was fractionated by column chromatography on phospho-cellulose. The dialyzate was applied to a column of phospho-cellulose (1ϫ10 cm) equilibrated with 50 mM of sodium phosphate buffer (pH 6.8); the column was then eluted with a linear gradient of NaCl (0-1.0 M) in 400 ml of the same buffer. The fraction with RNase activity eluted between 0.5-0.8 M was pooled and dialyzed against de-ionized water with dialysis tubing (molecular weight 1000 cut).
Step 4. The RNase active fraction was then applied to a column of heparin Sepharose CL6B (1ϫ10 cm) equilibrated with 20 mM of sodium acetate buffer (pH 5.5); the column was eluted with a linear gradient of NaCl (0-1.0 M) in 200 ml of the same buffer. The RNase active fraction and the protease inhibitor fractions were separately pooled and concentrated by Centricon 5000 (Millipore Japan) ( Fig. 1 ) (heparin fraction).
Assay for RNase RNase activity was essentially measured according to the method described by Reddi. 3) RNA (5 mg/ml) in 50 mM of Tris-HCl buffer (pH 7.5) was hydrolyzed at 37°C; the reaction was stopped by the addition of 1 ml of 20 mM Lanthanum nitrate in 15% perchloric acid, and the solution then centrifuged for 5 min at 3000 rpm. The supernatant (0.3 ml) was diluted with 2 ml of water, and then absorbancy at 260 nm was measured. One unit of RNase activity was defined as the amount of enzyme required to increase the absorbancy reading by 1.0 in 5 min.
Measurement of Trypsin Activity
Trypsin activity was measured spectrophotometrically by the increase in absorbancy at 405 nm using a substrate of N-CBZ-L-arginine-pnitroanilide (20 nmol) in 0.1 M of Tris-HCl buffer (pH 7.5) at 25°C.
Assay of Trypsin Inhibitor Potency
The potency of the trypsin inhibitor was estimated by comparing it to the potency of Type 1-P BPTI.
A reaction mixture containing 1 ml of 0.1 M Tris-HCl buffer (pH 7.5), 20 ml of 1 mM N-CBZ-L-arginine-p-nitroanilide, 10 ml of sample solution and 5 ml of trypsin (0.225 mg/ml) was prepared.
The reaction was monitored by following the change in absorption at 405 nm, and the initial rate was measured. The potency of the inhibitor was then calculated using the calibration curve obtained for 0-5 mg range of the standard inhibitor (BPTI).
Protein Concentration The protein concentration was estimated by assuming the absorbency of a 0.1% protein solution to be 1.0 at 280 nm.
Gel-Electrophoresis on Sodium Dodecyl Sulfate-Polyacrylamide Gel (SDS-PAGE) SDS-PAGE was performed using a 15% polyacrylamide gel according to the method described by Laemmli. 4) The gel was stained by silver staining using a kit purchased from Daiichi Chemicals (Tokyo). To detect the RNase activity, poly U (ca. 0.3 mg/ml) was added to the separation gel along with the customary reagents prior to polymerization as according to the method described by Blank et al., 5) except for the incubation in sodium acetate buffer (pH 6.0) instead of Tris-HCl buffer. The molecular weights of the proteins were determined using marker proteins purchased from Oriental Yeast (Tokyo).
Determination of Amino Acid Sequence The amino acid sequence of the peptides were determined by Edman degradation using an Applied Biosystems (ABI) 491cLC protein sequencer.
Reduction and S-Carboxymethylation of SE-Trypsin Inhibitor SE-trypsin inhibitor was reduced and S-carboxymethylated according to the method described by Crestfield et al. 6) Reduced and S-carboymethylated SE-trypsin inhibitor (RCM SE-trypsin inhibitor) was purified by SDS-PAGE, digested with V8 protease on a PVDF membrane and separated by a microblotter HPLC ABI1738 attached to an ABI 491cLC protein sequencer. Reagents and Kits for Molecular Cloning Taq DNA polymerase (EX Taq) was purchased from Takara Biochemicals (Shiga). PCR primers were obtained from Gensett K.K. (Kyoto). SuperScript II reversetranscriptase used for 5Ј-RACE and 3Ј-RACE, T4 DNA ligase were purchased from New England Biolabs Inc. (MA, U.S.A.). 5Ј-RACE and 3Ј-RACE were performed using system for the rapid amplification of cDNA ENDs, version 2.0, following RNA extraction using TRIZOL reagents (GIBCO BRL Life Technolgies, Inc., MD, U.S.A.).
Extraction of Total RNA TRIZOL reagent (1 ml) was added to a frozen Spirometra (0.1 g) and incubated for 5 min at room temperature. The RNA was extracted using chloroform (0.2 ml) and precipitated by isopropyl alcohol (0.5 ml) according to the instruction of the supplier. The RNA was dissolved in diethylpyrocarbonate treated water and the RNA concentration was spectrophotometrically determined at 260 nm.
Primers and Adapters Primers and adapters used in this paper are listed in Table 2 .
Single Stranded cDNA Synthesis by Reversetranscriptase Oligo dT primer (HIK-18VN) was added to the total RNA (1 mg) and incubated at 70°C for 10 min. SuperScript II reversetranscriptase (200 units) and 2.5 mM of dNTP were added to the solution and incubated at 42°C for 50 min. The resulting single stranded cDNAs were then used for cDNA amplification. SE-2F (Table 2 ) was designed according to the primary structure of the N-terminal region (Asp-Pro-CysLeu-Met-Pro-Val) in mature protein and used as a forward primer; HIK-ad1 was used as an adopter primer for 3Ј-RACE.
Primers, SE-73R and SE-63R (Table 2) were synthesized based on the the 3Ј-RACE. SE-73R (or SE-63R) was used for first strand cDNA synthesis for 5Ј-RACE. A dC homopolymeric tail was added to the first cDNA with terminal deoxynucleotidyl transferase. PCR was performed with SE-63R (or SE-73) as the reverse primer, and an Abridged Anchor Primer (AAP) was used as the forward primer as recommended by the kit for rapid amplification of cDNA ends kit as mentioned above (GIBCO BRL Life Technologies Inc., MD, U.S.A.). Cloning of cDNA of Spirometra 3Ј-RACE was ued to elucidate the 3Ј-region of the SE-trypsin inhibitor. SE-2F designed from the amino acid sequence of the inhibitor which corresponded to Asp3-Val9 as the primer and an adapter, HIK-ad1. A 300 base pair DNA fragment of the PCR product was gel-purified and ligated to a cloning vector. The DNA sequence of the insert was then analyzed. The sequence was identical with Arg10-Cys38, as determined by protein chemistry. To analyze the upstream region of the cDNA, 5Ј-RACE was performed between AAP and SE-63R. A 300 base pair fragment of the PCR product was gel-purified and ligated to the cloning vector, and the sequence of the signal peptides, including the N-terminal part of the inhibitor, was determined.
DNA Sequencing The DNA sequence was determined using Sanger and Coulson's method 7) and a DNA analyzer GENE READER 4200 DNA analyser (LI-COR, Inc., NE, U.S.A.). The DNA was labeled using a Thermo Sequenase cycle sequencing kit, (Amersham Pharmcia Biotech, Inc., OH, U.S.A.) and IRD 800 labeled M13 reverse and T7 universal primer obtained from Aloka Co., Ltd. (Tokyo).
Expression of SE-Trypsin Inhibitor
The SE-trypsin inhibitor was expressed from E. coli. An expression vector was constructed, starting from pET11d (Noagen) according to the methods described by Huang et al. 8) A pelB signal sequence was obtained from pET22b. The pelB 3Ј-end sequence with a modified NcoI site (see legend of Fig. 6 ) was combined with pET11d ( Fig. 6 ). NcoI and BamHI sites were added to the 5Ј-and 3Ј-end of the SE-trypsin inhibitor cDNA, respectively by PCR using 1SE5NcoI and 1SE3BamHI as primers. The latter also includes the sequence to modify the NcoI site in the original SE-trypsin inhibitor DNA without changing the encoding amino acid residue. The PCR product was purified and cloned with an @GEM-T easy vector system (Promega Co., U.S.A.). The cDNA was ligated to 3Ј-end of the modified pelB gene in pETT11d and named pET11d-pelB-1SE (Fig. 6 ). An electroporation system, GENE Pulser II (BioRad Laboratories, CA, U.S.A.) was used for the transformation.
The pET11d-pelB-1SE was expressed overnight in E. coli BL21(DE3)pLysE in terrific broth at 37°C, with shaking. Isopropyl-2-thio-b-D-galactoside (IPTG) (1 mM) was added to the culture medium when the medium reached to an absorbancy of about 0.6 at 260 nm. The expressed protein was recovered from the culture medium by centrifugation at 12000ϫg for 15 min. The supernatant was analyzed by SDS-PAGE, using the culture media without IPTG as a control.
RESULTS AND DISCUSSION
Partial Purification of Alkaline Ribonuclease and Trypsin Inhibitor from the Spirometra Alkaline RNase was partially purified from Spirometra as shown in Table 1 . The purity of the RNase fraction obtained from column chromatography using phospho-cellulose was evaluated by SDS-PAGE. RNase activity was only detected at a molecular weight of 21.5 kDa by activity staining on SDS-PAGE (Fig.  2b) , but was not by silver staining (Fig. 2a) . However, in the protease inhibitor fraction, two broad zones corresponding to about 30 kDa and 6.5-14.3 kDa were detected. The latter zone was transferred to a polyvinylidenedifluoride (PVDF) sheet by electroblotting, and the N-terminal amino acid sequence of the protein was determined up to the 41 residue (Fig. 3) .
In addition to the N-terminal sequence, we obtained 4 peptides (V1-V4) by reverse-phase HPLC of the V8 protease digestion of RCM SE-trypsin inhibitor (see determination of amino acid sequence, in Materials and Methods, precise chromatographic data not shown). The sequence of these peptides determined is also included in Fig. 3 . Proteins with similar amino acid sequences were surveyed in the protein data bank. Several proteins with molecular mass of about 9 kDa are shown in Fig. 4 . These proteins are all classified as trypsin inhibitors. Thus, the potency of trypsin inhibitor at each step in the purification procedure was determined similar way as BPTI ( Table 1 ). The trypsin inhibitor was purified from the crude extract by a factor of 23 up to step 4, and then further purified using SDS-PAGE to produce a single polypeptide sequence. Although, purity of this protein was clear from the sequence, the exact specific activity of this peptide was not determined by this method. However, the protein concentration (estimated from the protein density on SDS-PAGE) suggested that specific activity of the SE-trypsin inhibitor was roughly comparable to that of the standard BPTI (data not shown).
Amino Acid and Nucleotide Sequence of SE-Trypsin Inhibitor
To determine the complete amino acid sequence of this inhibitor, we attempted to analyze cDNA nucleotide sequence encoding this inhibitor using molecular cloning based on the partially determined amino acid sequence. The total RNA was extracted from the organism, and the cDNA encoding SE-trypsin inhibitor was cloned by PCR. The sequencing strategy is summarized in Fig. 3 . The 3Ј-unknown sequence of cDNA was amplified using a SE-2F (Table 2) designed according to the amino acid sequence of the N-terminal part of the inhibitor as the forward primer and HIKad1 as an adopter primer. The PCR products were analyzed both forward and in the reverse direction to give the nucleotide sequence of the SE-trypsin inhibitor downstream of the known sequence, including the stop codon. The sequence includes the amino acid sequence determined by protein chemistry (Arg1-Asn41), an additional 25 amino acid residues and the stop codon. The nucleotide sequence upstream of the N-terminal sequence was amplified by 5Ј-RACE using SE-63R and an AAP primer. By analyzing the nucleotide sequence of the fragment, we identified a putative signal sequene consisting of 18 or 19 amino acid residues and the N-terminal part of the SE inhibitor. We concluded that the SE trypsin inhibitor consists of 68 amino acid residues and has a molecular mass of 7796 Da (Figs. 3 and  4) .
Specificity of SE-Trypsin Inhibitor
The specificity of the SE-trypsin inhibitor was tested using an assay method that is similar to the one used for trypsin inhibition. The preliminary results indicate that the K i value for trypsin is about 0.4ϫ10 Ϫ12 M and about 1.6 fold higher than that of BPTI. The K i values for a-chymotrysin and lysylendopeptidase of SE-inhibitor were 7-10 fold larger than that for trypsin. However, the SE-trypsin inhibitor does not inhibit elastase and subtilisin.
Comparison of the SE-Trypsin Inhibitor's Amino Acid Sequence with Those of Other Trypsin Inhibitors The amino acid sequence of the SE-trypsin inhibitor was compared with those of the other BPTI-like trypsin (or chymotrypsin) inhibitors of various origins (Fig. 4) . The Fig. 4 shows that 6 half-cystine residues, three tyrosine (partly replaced by tryptophane) and two phenylalanine residues (partly replaced by tyrosine) are located at the same positions in the other inhibitors. Thus, the SE-inhibitor is likely to be a homologous protein of trypsin inhibitor exemplified by BPTI. The lysine residue at the active site of BPTI was replaced by Arg, as also occurs in human pancreatic inhibitor. These data suggest that the mechanism of the SE-trypsin inhibitor is very similar to those of the other inhibitors listed in Fig. 4 . The phylogenetic relationship of these trypsin inhibitors was analyzed by the most likelihood, inference method developed by Adachi and Hasegawa (Fig. 5) . 17) It is very interesting that the SE-inhibitor is closely related to higher animals, rather than those in other parasites, such as hookworm. However, the difference among all inhibitors is very small (20-31 residues), and small differences may have a considerable effect on the phylogenetic tree.
A Trial to Express SE-Trypsin Inhibitor in E. coli To further confirm the structure of the SE-trypsin inhibitor, we used E. coli to express the inhibitor and test the inhibitor's function. An expression vector pET11d-pelB-1SE was constructed, starting from pET11d (Noagen) according to the methods described by Huang et al. 8) as decribed in Materials and Methods. A pelB signal sequence was obtained from pET22b. The pelB 3Ј-end sequence with a modified NcoI site (see legend of Fig. 6 ) was combined with pET11d ( Fig. 6) . NcoI and BamHI sites were added to the 5Ј-and 3Ј-end of the SE-trypsin cDNA, respectively by PCR using 1SE5NcoI ; see anemone, trypsin inhibitor from Anemonia sulcata 10) ; naja1, trypsin inhibitor from cobra, Naja nirea 11) ; naja2, chymotrypsin inhibitor cobra, Naja naja 12) ; silkworm, chymotrypsin inhibitor from Lavrval hemolymph 13) ; hookworm broad protease inhibitor from hookworm Ancylostoma selonicum 1) ; loggerhead, trypsin inhibitor from Carett caretta 14) ; human, human trypsin inhibitor. 15) Active site of BPTI is indicated by an adverse triangle (᭢).
Fig. 5. Phylogenetic Tree of Trypsin Inhibitors
The tree was constructed accoding to the method of Adachi and Hasegawa. 17) All notaions are the same as those in Fig. 4 . Fig. 6 . Construction of Expression Vector, pET11d-pel-1SE
In this expression system, to cleave the signal peptide at appropriate site, the presence of an Ala residue at the C-terminal of the signal peptide is necessary. Thus, we inserted an Ala residue on the 3Ј-side of the signal peptide. pETT11d and named pET11d-pelB-1SE (Fig. 6 ). An electroporation system, GENE Pulser II (Bio-Rad Laboratories, CA, U.S.A.) was used for the transformation of pET11d-pelB-1SE into E. coli BL21(DE3)pLysE.
The pET11d-pelB-1SE was expressed overnight in BL21(DE3)pLysE in terrific broth at 37°C, with shaking. IPTG (1 mM) was added to the culture medium when the medium reached to an absorbancy of about 0.6 at 260 nm. The expressed protein was recovered from the culture medium by centrifugation. The inhibitor content in the supernatant was estimated by trypsin inhibitor assay to be 0.68 mg/l. The supernatant obtained from the culture media without IPTG was used as a control. However this expression system was not stable and the amount of inhibitor expressed decrease by repeated use of the transformant by unkown reason. Therefore we need further studies to obtain constant expression system.
